General procedures of the synthesis of compound 3: To a stirred solution of 2 [1] [2] [3] (1.2 eq.), triethylamine (5.0 eq.) and 1 4 (1.0 eq.) in DMF were added DMT-MM (1.5 eq.) and the mixture was stirred for 2 h. Then CHCl 3 was added, and the mixture was washed with saturated aqueous solution of NaHCO 3 and that of NaCl. The solvent was removed in vacuo. The residue was purified by silica gel column chromatography using chloroform and methanol as eluent (3% triethylamine was added). After column chromatography, products were collected by re-precipitation using ether and hexane.
General procedures for the synthesis of phosphoramidite monomers (compound 4): In dry dichloromethane under nitrogen, compound 3 (1.0 eq.) and triethylamine (5.0 eq.) were reacted with 2-cyanoethyl diisopropylchlorophosphoramidite (2.0 eq.) at 0 o C.
After 30 min, the reaction mixture was diluted with excess ethyl acetate and washed with saturated aqueous solutions of NaHCO 3 and of NaCl. The solvent was removed by evaporation, and the crude mixture was subjected to silica gel column chromatography to afford compound 4. Chloroform and acetone were used as eluent (3% triethylamine was added) for 4 containing iBu G. Hexane, ethyl acetate and triethylamine were used for the others. After column chromatography, products were re-precipitated twice from hexane. Before the synthesis of L-aTNA on a DNA synthesizer, 4 were dried by coevaporation with dry acetonitrile.
Obtained amounts for compound 4 were shown below. Synthesis and purification of oligonucleotides:
aTN8c, L-aTN15a, and L-aT15b) were synthesized using an ABI 3400 DNA/RNA synthesizer using phosphoramidite chemistry as described in a previous report. 5 Synthesized oligonucleotides were purified using Poly-Pak cartridges and reversedphase HPLC (Merck LiChrospher 100 RP-18(e) column). After purification, synthesized oligonucleotides were characterized by MALDI-TOF MS. 
